How about you? Do you contribute to the containment of Antimicrobial Resistance that threats us all?
We at Molsid do our part. We develop the first truly rapid test for AMR in primary clinical samples. That’s why we are an official contender for the Longitude Prize that calls for just such a test that’s rapid first and foremost, but also accurate and affordable.
Our molecular technology stays inhouse, but we welcome offers for partnering on the development of the kits and the test’s dedicated PoC reader.
Recent posts
It was a pleasure for MOLSID, represented by its Executive Director Younes Lazrak, to present our product pipeline at this year’s ESCMID GLOBAL. Many thanks
A new fundraising round has been opened and will close in Q1 2024, with existing and new investors. This round will allow us to speed
We have updated our corporate clip. Have a look to learn more about who we are and what we do!
Get in touch
Technologie
Applications
Company
